Followup of Patients With Interstitial Cystitis Responsive to Treatment With Intravesical Bacillus Calmette-Guerin or Placebo
Authors:
- Kathleen Joy PropertKPKathleen Joy Propert
- Valerie TealVTValerie Teal
- Interstitial Cystitis Clinical Trials GroupIGInterstitial Cystitis Clinical Trials Group
- 1 February 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 179 (2) , 552-555
Abstract
We evaluated the longer term response in patients with interstitial cystitis who initially responded to intravesical bacillus Calmette-Guerin or placebo in a randomized clinical trial. Patients with interstitial cystitis who responded positively to treatment with bacillus Calmette-Guerin or placebo after 34 weeks of followup in a double-blind clinical trial were followed for an additional 34 weeks in an observational study to assess response durability. Outcomes at 68 weeks included a patient reported global response assessment, 24-hour voiding diary, and pain, urgency and validated interstitial cystitis symptom indexes. Of responders to bacillus Calmette-Guerin or placebo in the clinical trial 38 continued extended followup in the observational study. A total of 12 (75%) responders who received placebo and 19 (86%) who received bacillus Calmette-Guerin considered themselves to remain moderately or markedly improved at week 68. Improved symptom outcomes were also generally maintained during followup in the 2 groups. Most patients who respond to therapy with intravesical bacillus Calmette-Guerin or placebo maintain improved symptoms for up to 68 weeks after the initiation of therapy. However, initial response rates are low and placebo responders demonstrated essentially the same durability of response as bacillus Calmette-Guerin responders. These results argue against the routine use of bacillus Calmette-Guerin in this patient group.Keywords
This publication has 9 references indexed in Scilit:
- A RANDOMIZED CONTROLLED TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR TREATMENT REFRACTORY INTERSTITIAL CYSTITISJournal of Urology, 2005
- TRANSDERMAL POSTERIOR TIBIAL NERVE LASER THERAPY IS NOT EFFECTIVE IN WOMEN WITH INTERSTITIAL CYSTITISJournal of Urology, 2004
- A Pilot Clinical Trial of Oral Pentosan Polysulfate And Oral Hydroxyzine in Patients With Interstitial CystitisJournal of Urology, 2003
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- A High-Efficiency Microwave Thermoablation System for the Treatment of Benign Prostatic Hyperplasia: Results of a Randomized, Sham-Controlled, Prospective, Double-Blind, Multicenter Clinical TrialUrology, 1998
- THE EFFICACY OF INTRAVESICAL BACILLUS CALMETTE-GUERIN IN THE TREATMENT OF INTERSTITIAL CYSTITIS: LONG-TERM FOLLOWUPJournal of Urology, 1998
- PSYCHOMETRIC ANALYSIS OF THE UNIVERSITY OF WISCONSIN INTERSTITIAL CYSTITIS SCALE: IMPLICATIONS FOR USE IN RANDOMIZED CLINICAL TRIALSJournal of Urology, 1998
- Placebo therapy of benign prostatic hyperplasia: a 25‐month studyBritish Journal of Urology, 1998
- The interstitial cystitis symptom index and problem indexUrology, 1997